Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Control Bionics Ltd. ( (AU:CBL) ) has shared an announcement.
Control Bionics Ltd. has announced the quotation of 8,852,473 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of September 17, 2025. This move is part of a previously announced transaction, potentially enhancing the company’s market presence and providing additional capital to support its operations and growth strategies.
More about Control Bionics Ltd.
Control Bionics Ltd. operates in the biotechnology industry, focusing on developing and providing assistive technology solutions. The company specializes in creating products that enable individuals with disabilities to communicate and interact with their environment, emphasizing market segments that require advanced communication aids.
Average Trading Volume: 137,709
Technical Sentiment Signal: Sell
Current Market Cap: A$12.02M
For an in-depth examination of CBL stock, go to TipRanks’ Overview page.